Expert consensus on thrombolytic therapy for ST-segment elevation myocardial infarction
10.3969/j.issn.1004-8812.2024.07.002
- VernacularTitle:急性ST段抬高型心肌梗死溶栓治疗专家共识
- Author:
Cardiology Branch of Jiangsu Medical Association
;
Cardiology Branch of Jiangsu Medical Doctor Association
;
Cardiac Critical Care Specialized Committee of Jiangsu Medical Doctor Association
;
Basic & Medication Panel Affiliated to Cardiology Branch of Jiangsu Medical Association
;
Chun-Jian LI
;
Gen-Shan MA
;
Biao XU
;
Xiang-Qing KONG
- Keywords:
Myocardial infarction;
Thrombolytic therapy;
Expert consensus
- From:
Chinese Journal of Interventional Cardiology
2024;32(7):364-382
- CountryChina
- Language:Chinese
-
Abstract:
Thrombolytic therapy plays a vital role in reperfusion strategy for ST-segment elevation myocardial infarction(STEMI)patients.Previous Chinese expert consensus focused on pre-hospital thrombolysis therapy in STEMI patients was published in 2018 which tremendously promoted pre-hospital thrombolysis therapy.In recent years,plenty of research progress and results of clinical trials have been released in following areas such as STEMI reperfusion strategy,anti-platelet/anti-coagulants therapy,contemporary facilitated percutaneous coronary intervention,and so on.Meanwhile,the COVID-19 pandemic makes timely reperfusion for STEMI patients even more challenging.Therefore,this consensus has been proposed aiming to summarize recent progress in STEMI thrombolysis therapy and to provide practical & evidence-based instructions conforming to national conditions.We hope this consensus will contribute to the emergency management and long-term prognosis of STEMI patients.
